Guriqbal “Guriq” S. Basi, Ph.D. has been appointed chief scientific officer, Sarepta Therapeutics, Inc. Dr. Basi brings 30 years of experience having held roles of increasing responsibility at Elan and other biotechnology companies. Dr. Basi will report to Douglas Ingram, Sarepta’s chief executive officer, and will be responsible for leading the direction of the company’s discovery pipeline and translational research efforts.  Dr. Basi previously served as chief science and technology officer...